AMRX Financing Cash Flow

Amneal Pharmaceuticals Inc Class A · Financing Cash Flow

AMRX logo

AMRX Financing Cash Flow

Latest reported$69.63M
AMRX TTM Cash from Financing (-$95.02M → $69.63M)
High-resolution chart · PNG

AMRX financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amneal Pharmaceuticals Inc Class A Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
69,629,000
-49,437,000
-31,530,000
-82,614,000
-234,403,000
-227,802,000
-211,791,000
-251,419,000
-245,658,000
-222,828,000
-212,573,000
-133,908,000
-93,455,000
-57,950,000
-62,622,000
-70,805,000
-68,228,000
-129,545,000
-138,122,000
-119,054,000
-90,307,000
-362,321,000
131,807,000
135,791,000
143,003,000
444,010,000
-45,833,000
-257,455,000
-167,259,000
299,057,000
287,675,000
507,091,000
360,717,000
-100,313,000
-95,015,000
-104,487,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.